Cargando…

Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist’s dilemma

Detalles Bibliográficos
Autores principales:	Parajuli, Niraj, Poudyal, Yogesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031444/ https://www.ncbi.nlm.nih.gov/pubmed/33830989 http://dx.doi.org/10.1371/journal.pntd.0009039

Ejemplares similares

Rabies postexposure prophylaxis in the United States: Opportunities to improve access, coordination, and delivery
por: Howington, Gavin T., et al.
Publicado: (2021)

Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy
por: Mieras, Liesbeth, et al.
Publicado: (2016)

Single-dose rifampicin chemoprophylaxis protects those who need it least and is not a cost-effective intervention
por: Lockwood, Diana N. J., et al.
Publicado: (2018)

Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)

Ribavirin for Lassa Fever Postexposure Prophylaxis
por: Hadi, Christiane M., et al.
Publicado: (2010)

The Nepalese health care system and challenges during COVID-19
por: Neupane, Prajwal, et al.
Publicado: (2021)

A Dermatologist's Ammunition in the War Against Smoking: A Photoaging App
por: Brinker, Titus Josef, et al.
Publicado: (2017)

Rabies postexposure prophylaxis survey--Kentucky, 1994.
por: Auslander, M, et al.
Publicado: (1997)

HIV postexposure prophylaxis in the 21st century.
por: Henderson, D K
Publicado: (2001)

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
por: Yamada, Kentaro, et al.
Publicado: (2016)

HIV postexposure prophylaxis during COVID-19
por: Junejo, Muhammad, et al.
Publicado: (2020)

A flexural exanthem following postexposure prophylaxis
por: Roche, Darren, et al.
Publicado: (2022)

Postexposure‐vaccine‐prophylaxis against COVID‐19
por: Shmuelian, Zohar, et al.
Publicado: (2022)

Cutaneous Manifestations of Anabolic-Androgenic Steroid Use in Bodybuilders and the Dermatologist’s Role in Patient Care
por: Furth, Garrett, et al.
Publicado: (2023)

Rabies Postexposure Prophylaxis, Marseille, France, 1994–2005
por: Gautret, Philippe, et al.
Publicado: (2008)

Rabies Postexposure Prophylaxis, New York, 1995–2000
por: Blanton, Jesse D., et al.
Publicado: (2005)

Effect of Media Warnings on Rabies Postexposure Prophylaxis, France
por: Gautret, Philippe, et al.
Publicado: (2011)

Anthrax Postexposure Prophylaxis in Postal Workers, Connecticut, 2001
por: Williams, Jennifer L., et al.
Publicado: (2002)

Antimicrobial Postexposure Prophylaxis for Anthrax: Adverse Events and Adherence
por: Shepard, Colin W., et al.
Publicado: (2002)

Risk of Rabies and Implications for Postexposure Prophylaxis Administration in the US
por: Charniga, Kelly, et al.
Publicado: (2023)

Inclusion of Rabishield in the WHO guidelines for rabies postexposure prophylaxis
por: Kaza, Vamsi Krishna, et al.
Publicado: (2023)

COVID-19, leprosy, and neutrophils
por: Schmitz, Veronica, et al.
Publicado: (2021)

Facemasks Readily Available in Common Stores used by Nepalese, How much Protection is Enough Protection against COVID-19?
por: Sunuwar, Neela, et al.
Publicado: (2021)

Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin
por: Barth-Jaeggi, Tanja, et al.
Publicado: (2016)

Rabies encephalitis in a preschool child following postexposure prophylaxis
por: Chaitra, K. M., et al.
Publicado: (2021)

Bat Rabies and Human Postexposure Prophylaxis, New York, USA
por: Eidson, Millicent, et al.
Publicado: (2011)

Terrestrial Rabies and Human Postexposure Prophylaxis, New York, USA
por: Eidson, Millicent, et al.
Publicado: (2010)

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
por: Boulware, David R., et al.
Publicado: (2020)

Postexposure prophylaxis during COVID-19 lockdown in Melbourne, Australia
por: Chow, Eric P F, et al.
Publicado: (2020)

The Missing Millions: A Threat to the Elimination of Leprosy
por: Smith, William Cairns, et al.
Publicado: (2015)

Facial Tuberculoid Leprosy
por: Parajuli, Niraj, et al.
Publicado: (2022)

Cost-Effectiveness of a Chemoprophylactic Intervention with Single Dose Rifampicin in Contacts of New Leprosy Patients
por: Idema, Willemijn J., et al.
Publicado: (2010)

Trend analysis of leprosy in Morocco between 2000 and 2017: Evidence on the single dose rifampicin chemoprophylaxis
por: Khoudri, Ibtissam, et al.
Publicado: (2018)

Implementation approaches for leprosy prevention with single-dose rifampicin: A support tool for decision making
por: ter Ellen, Fleur, et al.
Publicado: (2022)

Leprosy treatment: Can we replace opinions with research?
por: Scollard, David M.
Publicado: (2020)

Will cases of leprosy reaction increase with COVID-19 infection?
por: Antunes, Douglas Eulálio, et al.
Publicado: (2020)

Chronic Urticaria and Its Impact on the Quality of Life of Nepalese Patients
por: Paudel, Sushil, et al.
Publicado: (2020)

High yield of retrospective active case finding for leprosy in Comoros
por: Ortuño-Gutiérrez, Nimer, et al.
Publicado: (2022)

Correction: Rabies encephalitis in a preschool child following postexposure prophylaxis
Publicado: (2021)

Sexual Assault: A Report on Human Immunodeficiency Virus Postexposure Prophylaxis
por: Griffith, William F., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_snlgo4l6ualgo2n146r8rjjec0